Cart (0 Items)
Your cart is currently empty.
View ProductsGontivimab Biosimilar – Anti-RSV glycoprotein F mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Gontivimab Biosimilar - Anti-RSV glycoprotein F mAb - Research Grade |
|---|---|
| Source | Drugbank DB16179 |
| Species | Lama glama |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Applications | ELISA,WB |
| Aliases /Synonyms | Gontivimab ,ALX-0171,VR-465,RSV glycoprotein F,anti-RSV glycoprotein F |
| Reference | PX-TA1405 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | VH-VH-VH |
| Clonality | Monoclonal Antibody |
Description of Gontivimab Biosimilar - Anti-RSV glycoprotein F mAb - Research Grade
General information on Anti-RSV glycoprotein F[Respiratory syncytial virus] (Gontivimab ) Monoclonal Antibody
Gontivimab is investigated for the treatment and prevention of Respiratory Syncytial Virus (RSV) Infection.
Related products
Antigen
HRSV-A2 Pre-F-Fusion glycoprotein F0 recombinant protein
PX-P6126 395€
SIL
Reviews
Il n’y a pas encore d’avis.